EORTC embarked on a membership renewal programme
5 Feb 2021
In 2020, EORTC embarked on an ambitious membership renewal programme, in order to comply with GDPR regulation and to ensure that all information of its members are up to date. Following this renewal programme, EORTC can confirm over 2800 direct members coming from 730 institutions. The network comprises of members coming from 48 countries around the world, with the top ten from Europe.
EORTC is a truly multidisciplinary organisation of which 15% are organ specialists. Its membership spans over 30 different disciplines conducting clinical research.
“One of the uniqueness of EORTC is that we conduct trials across multiple tumours and the members are stratified across groups related to their tumour of interest. We are able to attract leading clinical researchers across the globe, conducting practice changing trials,” said Denis Lacombe, EORTC Director General. “As EORTC approaches its 60th anniversary next year, we remain fully committed to all cancer patients, our members, partners and supporters, ensuring the organisation stays true to its mission and paves the way to innovation in cancer care.”
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023